김
김운장 Président Honoraire
Other M
Explore the complete record of transactions filed by 김운장, Président Honoraire. Officer active across 1 company, notably 대화제약. Aggregated, 26 disclosures have been published. History available since 5 March 2026. The latest transaction was filed on 27 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Declarations 26 total
● 대표이사 · Executives · 28 May 2026 (filed) · 대화제약 2,319 shares Share DART:20260528000282 Ideal exit: 22 Feb 2027 (T+270) ● 대표이사 · Executives · 27 Apr 2026 · 대화제약 1,750 shares @ ₩14,648.7314 0.0000% mcap 15.8% of flow Share DART:20260514000589 Ideal exit: 22 Jan 2027 (T+270) ● 명예회장 · Executives · 17 Apr 2026 · 대화제약 3,500 shares @ ₩14,893.00 0.0000% mcap 100.0% of flow Share DART:20260424000433 ● 대표이사 · Executives · 14 Apr 2026 · 대화제약 1,000 shares @ ₩13,909.73 0.0000% mcap 8.5% of flow Share DART:20260421000391 Ideal exit: 9 Jan 2027 (T+270) ● 대표이사 · Executives · 19 Mar 2026 · 대화제약 4,450 shares @ ₩14,758.8369 0.0000% mcap 40.5% of flow Share DART:20260327000820 Ideal exit: 14 Dec 2026 (T+270) ● 대표이사 · Executives · 5 Mar 2026 · 대화제약 3,550 shares @ ₩14,228.9367 0.0000% mcap 35.2% of flow Share DART:20260312000426 ● Executives · 16 Dec 2025 (filed)
● Executives · 1 Oct 2025 (filed)
● Executives · 5 Aug 2025 (filed)
● Executives · 23 Apr 2025 (filed)
● Executives · 7 Mar 2025 (filed)
● Executives · 7 Feb 2025 (filed)
● 명예회장 · Executives · 25 Oct 2024 (filed) · 대화제약 Share DART:20241025000435 ● 명예회장 · Executives · 10 Oct 2024 (filed) · 대화제약 Share DART:20241010000569 ● 대표이사 사장 · Executives · 10 Oct 2024 (filed) · 대화제약 Share DART:20241010000474 Ideal exit: 7 Jul 2025 (T+270) ● Executives · 10 Oct 2024 (filed) · 대화제약 86,000 shares DART:20241010000490 ● 명예회장 · Executives · 30 Sept 2024 (filed) · 대화제약 Share DART:20240930000464 ● 대표이사 사장 · Executives · 24 Sept 2024 (filed) · 대화제약 Share DART:20240924000073 Ideal exit: 21 Jun 2025 (T+270) ● 명예회장 · Executives · 29 Aug 2024 (filed) · 대화제약 Share DART:20240829001151 ● 명예회장 · Executives · 12 Aug 2024 (filed) · 대화제약 Share DART:20240812000242 ● 대표이사 사장 · Executives · 12 Aug 2024 (filed) · 대화제약 Share DART:20240812000255 Ideal exit: 9 May 2025 (T+270) ● Executives · 7 Feb 2024 (filed)
● Executives · 7 Feb 2024 (filed)
● Executives · 10 Feb 2023 (filed)
● Executives · 17 Jan 2023 (filed)
25 of 26 declarations
Load more (1 remaining) About 김운장 Kim Un-jang is the Honorary Chairman of 대화제약, where he contributes to the strategic direction of the company. Although there are no detailed insights into his specific functions, his role is crucial for the smooth operation and growth of 대화제약.